Edward P. Feener, CHIEF SCIENTIFIC OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 16,176 shares at $11.76 ($190K) on 2024-05-20, disclosed to the SEC on 2024-05-21.
Scheduled sale ($190k) by CHIEF SCIENTIFIC OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.76 | 8,088 | $95K | 50.0% |
| 2 | $11.76 | 8,088 | $95K | 50.0% |
| Total | $11.76 avg | 16,176 | $190K | 100% |
| Filing → |
| KALV | SELL | 2024-01-12 | $591K | — | Filing → |
| KALV | SELL | 2024-01-10 | $449K | — | Filing → |
| KALV | SELL | 2023-11-21 | $41K | — | Filing → |